| Literature DB >> 33116916 |
Girma Tenkolu Bune1, Alemayehu Worku Yalew2, Abera Kumie3.
Abstract
BACKGROUND: Intensive access to antiretroviral therapy improved the prognosis of HIV. As a result, a non-communicable disease risk marker known as metabolic syndrome (MS) has emerged. It is a public health issue in sub-Saharan Africa including Ethiopia. However, there is little literature on predictors of MS among people living with HIV (PLHIVs) in the study area context.Entities:
Keywords: Gedeo zone; metabolic syndrome; predictors; risk factors; southern-Ethiopia
Year: 2020 PMID: 33116916 PMCID: PMC7547778 DOI: 10.2147/HIV.S275283
Source DB: PubMed Journal: HIV AIDS (Auckl) ISSN: 1179-1373
Bivariable Analysis, Socio-Economic and Demographic Factors and MS, Cases and Controls, PLHIVs, Gedeo-Zone, Southern Ethiopia, 2019
| Predictors | Metabolic Syndrome | COR (95% CI) | P-value | |
|---|---|---|---|---|
| Cases (n=139) | Controls (n=494) | |||
| Number | Number | |||
| ≤34 | 42 | 273 | ||
| 35–44 | 52 | 151 | 2.24 (1.42–3.52)* | <0.01** |
| ≥45 | 45 | 70 | 4.18 (2.55–6.86) | <0.01** |
| Single | 22 | 123 | 1 | |
| Married | 42 | 147 | 1.60 (0.91–2.82) | 0.11 |
| Separated | 29 | 106 | 1.53 (0.83–2.82) | 0.17 |
| Widowed | 46 | 118 | 2.18 (1.24–3.84) | <0.01** |
| No formal schooling | 39 | 124 | 1 | |
| Less than 1° school | 24 | 99 | 0.77 (0.44–1.37) | 0.09*** |
| 1°school completed | 45 | 166 | 0.86 (0.53–1.40) | 0.25 |
| 2nd school completed | 16 | 68 | 0.75 (0.39–1.44) | 0.08*** |
| High school completed | 15 | 37 | 1.15 (0.49–2.66) | 0.60 |
| Government employed | 24 | 60 | 1 | |
| NGO-employed | 7 | 20 | 2.44 (1.05–5.71) | 0.18 |
| Self-employed | 67 | 261 | 2.14 (0.70–6.51) | 0.24 |
| Student | 12 | 67 | 1.57 (0.74–3.34) | 0.57 |
| Homemaker | 29 | 86 | 1.53 (0.36–6.50) | 0.08*** |
| Lowest | 12 | 18 | 1 | |
| second | 31 | 114 | 0.41 (0.18–0.94) | 0.04* |
| middle | 8 | 59 | 0.20 (0.07–0.58) | 0.01** |
| Fourth | 28 | 119 | 0.35 (0.15–0.82) | 0.02* |
| Men | 52 | 205 | 1 | |
| Women | 87 | 289 | 1.19 (0.81–1.75) | 0.39 |
| Urban | 94 | 312 | 1 | |
| Rural | 45 | 182 | 1.22 (0.82–1.82) | 0.33 |
Notes: *Significant at P<0.05, **Significant at P<0.01, ***Significant at P<0.1. Predictors: Age groups in year, Educational status, Ethnicity, Marital status, Occupation, Wealth index in quintile, sex, place of residence. Outcome: cases with Metabolic Syndrome (MS), control without MS.
Abbreviations: MS, metabolic syndrome; PLHIVs, people living with HIV; 1°, primary; 2nd, secondary; COR, crude odd ratio; AOR, adjusted odds ratio.
Bivariable Analysis, in the HIV/AIDS-Associated Factors and MS, Cases, and Controls PLHIVs, Gedeo-Zone, Southern Ethiopia, 2019
| Predictors | Metabolic Syndrome | COR (95% CI) | P-value | |
|---|---|---|---|---|
| Cases (n=139) | Controls (n=494) | |||
| Number | Number | |||
| ART-naive | 44 | 167 | 1 | |
| ART exposed | 95 | 327 | 1.14 (1.00–1.75) | 0.02* |
| Non-in ether of the two Therapy | 44 | 167 | 1 | |
| 1st line | 88 | 324 | 1.03 (0.69–1.55) | 0.90 |
| 2nd line | 7 | 3 | 8.86 (2.20–35.65) | 0.02* |
| AZT-3TC-NVP | 12 | 67 | 1.65 (0.609–4.50) | 0.14 |
| AZT-3TC-EFV | 8 | 27 | 1.37 (0.68–2.73) | 0.98 |
| TDF-3TC-EFV | 47 | 193 | 3.19 (1.40–7.27) | 0.37 |
| TDF + 3TC+ NVP | 20 | 35 | 1.91 (1.01–3.58) | 0.05*** |
| ABC + 3TC + EFV | 1 | 2 | 1.69 (0.84–3.34) | 0.93 |
| NA/Not applicable | 51 | 170 | 1 | 1 |
| AZT-3TC-LPV/r | 4 | 1 | 14.88 (0.65–134.24) | 0.32 |
| TDF-3TC-ATV/r; | 0 | 1 | NC | NC |
| TDF-3TC-ATV/r | 2 | 0 | NC | NC |
| ABC + 3TC + LPV | 1 | 1 | 3.72 (0.23–59.87) | 0.35 |
| NA/Not applicable | 132 | 491 | 1 | |
| <1 year | 19 | 69 | 1 | |
| 1–4 Years | 47 | 173 | 0.99 (0.54–1.80) | 0.96 |
| 5–9 Years | 11 | 51 | 0.78 (0.34–1.79) | 0.56 |
| 1–4 Years | 13 | 48 | 1 | |
| 5–9 Years | 27 | 71 | 1.40 (0.66–3.00) | 0.38 |
| Ambulatory | 49 | 123 | 1 | |
| Working | 90 | 371 | 1.14 (1.00–1.75) | 0.02* |
| <III stage | 99 | 390 | 1 | |
| ≥III stage | 37 | 97 | 1.50 (00.97–2.33) | 0.07*** |
| No | 110 | 429 | 1 | |
| Yes | 29 | 65 | 0.58 (0.35–0.93) | 0.03* |
| No | 117 | 424 | 1 | |
| Yes | 22 | 70 | 1.14 (0.68–1.92) | 0.62 |
| <350 | 18 | 69 | 1 | |
| 350–500 | 38 | 110 | 1.32 (0.70–2.50) | 0.39 |
| ≥500 | 83 | 315 | 1.01 (0.57–1.79) | 0.97 |
| No | 130 | 480 | 1 | |
| Yes | 9 | 14 | 2.37 (1.00–5.61) | 0.05*** |
Notes: *significant at P<0.05, ***Significant at P<0.1. Predictors: ART status, Type of ART regimen,1st line ART regimen, OI other than TB, Functional status, WHO staging, Viral RNA levels ≥ 1500 copies per mL, CD4-levels cells mm3, Duration since on ART, Duration since diagnosed with HIV. Outcome: cases with Metabolic Syndrome (MS), control without MS.
Abbreviations: MS, metabolic syndrome; Rx –Therapy; HIV, human immunodeficiency virus; PLHIVs, people living with HIV, ART, antiretroviral therapy; 1st, first; 2nd, second; OI, opportunistic infections; TB, tuberculosis; WHO, world health organizations; RNA, ribonucleic acid; mL, milliliter; mm3, cubic millimeter; COR, crude odds ratio; AOR, adjusted odds ratio.
Bivariable Analysis, in the Behavioral Risk Factors and MS, Cases and Controls, PLHIVs, in the Gedeo-Zone, Southern Ethiopia, 2019
| Predictors | Metabolic Syndrome | COR (95% CI) | P-value | |
|---|---|---|---|---|
| Cases (n=139) | Controls (n=494) | |||
| Number | Number | |||
| Non-smoker | 98 | 376 | 1 | |
| All smoker | 41 | 118 | 1.33 (0.88–2.03) | 0.18 |
| Past smoker | 23 | 72 | 1 | |
| Current smoker | 18 | 46 | 0.82 (0.4–1.67) | 0.58 |
| Lifetime abstainer | 66 | 267 | 1 | |
| Consumer | 73 | 227 | 1.30 (0.89–1.90) | 0.17 |
| No | 99 | 397 | 1 | |
| Yes | 40 | 97 | 1.65 (1.08–2.54) | 0.02* |
| No | 87 | 347 | 1 | |
| Yes | 52 | 147 | 1.41 (0.95–2.09) | 0.29 |
| <5 servings | 16 | 96 | 1 | |
| ≥5 servings | 123 | 398 | 1.85 (1.05–3.27) | 0.03* |
| Vegetable oil | 10 | 32 | 1 | |
| Butter | 33 | 51 | 2.07 (0.90–4.77) | 0.09*** |
| Margarine | 20 | 142 | 0.45 (0.19–1.06) | 0.07*** |
| Solid fats | 67 | 218 | 0.98 (0.46–2.11) | 0.97 |
| Do not know | 9 | 51 | 0.57 (0.21–1.54) | 0.26 |
| 1 | ||||
| Far too much | 56 | 197 | 1.28 (0.50–3.25) | 0.61 |
| Too much | 58 | 198 | 1.32 (0.52–3.35) | 0.56 |
| Just the right amount | 19 | 72 | 1.19 (0.43–3.29) | 0.74 |
| Inactive | 27 | 81 | 1 | |
| Active | 112 | 413 | 0.81 (0.50–1.32) | 0.09*** |
| No | 91 | 280 | 1 | |
| Yes | 48 | 214 | 0.69 (0.47–1.02) | 0.16 |
| No | 107 | 365 | 1 | |
| Yes | 32 | 129 | 0.85 (0.54–1.32) | 0.46 |
| No | 1 | |||
| Yes | 117 | 389 | 1.44 (0.87–2.38) | 0.06*** |
| No | 1 | |||
| Yes | 42 | 159 | 0.91 (0.60–1.38) | 0.66 |
| No | 22 | 105 | 1 | |
| Yes | 102 | 376 | 0.87 (0.56–1.33) | 0.51 |
| No | 1 | |||
| Yes | 15 | 61 | 0.86 (0.47–1.56) | 0.62 |
| No | 128 | 451 | 1 | |
| Yes | 11 | 43 | 0.90 (0.45–1.80) | 0.77 |
| No | 46 | 121 | 1 | |
| Yes | 93 | 373 | 0.95 (0.65–1.38) | 0.04* |
| No | 105 | 424 | 1 | |
| Yes | 34 | 70 | 1.96 (1.24–3.11) | 0.01** |
Notes: *Significant at P<0.05, **Significant at P<0.01, ***Significant at P<0.1. Predictors: Smoking state, all smoker, Alcohol consumption status, All alcoholic consumer, Average frequency of serving fruit/vegetables/day, Type of oil, Total physical activity state, Physical activity levels, High levels physical activity among physically active, Moderate physical activity, Low levels physical activity, Running sedentary life, Composited total physical activity from work, Composited total physical activity from transport, Composited total physical activity from recreation. Outcome: cases with Metabolic Syndrome (MS), control without MS.
Abbreviations: MS, metabolic syndrome; PLHIVs, people living with HIV; WHO, World Health Organizations; COR, crude odds ratio; AOR, adjusted odds ratio; GROPAFA, Global Recommendation of Physical Activity for Health.
Multivariable Analysis, in Between All Predictor and MS, Cases and Controls, PLHIVs, Gedeo-Zone, Southern-Ethiopia, 2019
| Predictors | Metabolic Syndrome | |
|---|---|---|
| AOR (95% CI) | P-value | |
| 1.09 (1.05–1.12) | 0.00** | |
| No formal schooling | 1 | |
| Less than 1° school | 0.76 (0.32–1.82) | 0.53 |
| 1°school completed | 0.63 (0.27–1.39) | 0.28 |
| 2nd school completed | 0.22 (0.06–0.79) | 0.02** |
| High school completed | 0.61 (0.14–2.58) | 0.50 |
| Single | 1 | |
| Married | 1.14 (0.46–2.83) | 0.77 |
| Separated | 0.89 (0.34–2.32) | 0.82 |
| Widowed | 1.63 (0.69–3.89) | 0.26 |
| Government employed | 1 | |
| NGO-employed | 0.39 (0.07–2.31) | 0.30 |
| Self-employed | 0.36 (0.12–1.03) | 0.06 |
| Student | 0.11 (0.24–0.51) | 0.01* |
| Homemaker | 0.42 (0.13–1.32) | 0.14 |
| Lowest | 1 | |
| second | 0.43 (0.16–1.14) | 0.09 |
| middle | 0.22 (0.06–0.79) | 0.02* |
| Fourth | 0.43 (0.15–1.21) | 0.11 |
| ART-naive | 1 | |
| ART exposed | 3.07 (1.37–6.89) | 0.01* |
| No | 1 | |
| Yes | 0.76 (0.30–1.98) | 0.58 |
| Ambulatory | 1 | |
| Working | 1.42 (0.73–2.76) | 0.30 |
| <III stage | 1 | |
| ≥III stage | 1.93 (0.85–4.39) | 0.12 |
| No | 1 | |
| Yes | 1.98 (0.39–9.92) | 0.40 |
| No | 1 | |
| Yes | 1.87 (0.91–3.82) | 0.09 |
| <5 servings | 1 | |
| ≥5 servings | 1.48 (0.48–4.58) | 0.40 |
| Vegetable oil | 1 | |
| Butter | 1.08 (0.32–3.63) | 0.90 |
| Margarine | 0.40 (0.12–1.29) | 0.13 |
| Solid fats | 1.18 (0.41–3.37) | 0.76 |
| Do not know | 0.48 (0.10–2.40) | 0.37 |
| Inactive | 1 | |
| Active | 0.36 (0.16–0.79) | 0.01** |
| No | 1 | |
| Yes | 3.83 (1.46–10.05) | 0.01* |
| No | 1 | |
| Yes | 2.05 (0.88–4.78) | 0.10 |
| No | 1 | |
| Yes | 1.47 (0.59–3.65) | 0.40 |
Notes: *Significant at P<0.05, **Significant at P<0.01. Predictors: Age in year, Educational status, Ethnicity, Marital status, Occupation, Wealth index in quintile, ART status, OI other than TB, Functional status, WHO staging, Viral RNA levels ≥ 1500 copies per mL, Alcohol consumption status, Average frequency of serving fruit/vegetables/day, Type of oil, Total physical activity state, low level of Physical activity, Running sedentary life, Daily chew Khat. Outcome: cases with Metabolic Syndrome (MS), control without MS.
Abbreviations: MS, metabolic syndrome; PLHIVs, people living with HIV; ART, antiretroviral therapy; OI, opportunistic infects; TB, tuberculosis; WHO, World Health Organizations; AOR, adjusted odds ratio, 1°, primary; 2nd, secondary.